MetaCap

agilon health inc. (AGL) vs Cryo-Cell International (CCEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

agilon health inc. (AGL) has outperformed Cryo-Cell International (CCEL) over the past year, gaining 481.3% versus a gain of 1.5%. Over five years, CCEL leads with a -66.3% price change compared with -83.3% for AGL. agilon health inc. is the larger company by market cap ($1.52 billion vs $33.5 million), about 45.3 times the size, while Cryo-Cell International is growing revenue faster (-1.3% vs -2.1%).

On valuation, agilon health inc. trades at a lower forward P/E (20.7x vs 207.5x for Cryo-Cell International). agilon health inc. converts more of its revenue into profit, with a net margin of -6.6% versus -7.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AGL+481.26%CCEL+1.47%
+776%+344%-88%
Nov 21, 20251 yearNov 20, 2026
AGL-84.81%CCEL-66.12%
+27%-39%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AGL versus CCEL key metrics
MetricAGLCCEL
Share price$90.24$4.15
Market cap$1.52B$33.46M
1-day change+0.83%0.00%
YTD return+423.89%+20.64%
1-year return+481.26%+1.47%
5-year return-83.28%-66.34%
Forward P/E20.70207.50
EPS (TTM)$-6.69$-0.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.93B$31.57M
Revenue growth (YoY)-2.11%-1.31%
Net income (latest FY)$-391.35M$-2.43M
Gross margin—76.63%
Operating margin-7.81%1.53%
Net margin-6.60%-7.70%
52-week high$133.04$5.45
52-week low$7.48$2.72
Distance from 52-week high-32.17%-23.85%
Analyst consensusbuy—
Avg. price target upside+38.33%—
Average volume226.26K13.02K
Shares outstanding16.80M8.06M
Employees85672
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • agilon health inc. is about 45.3 times larger than Cryo-Cell International by market value ($1.52B vs $33.46M).
  • AGL has outperformed CCEL by 479.8 percentage points over the past year.

About agilon health inc.

AGL stock →

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.

Health Care · Misc Health and Biotechnology Services · 856 employees

About Cryo-Cell International

CCEL stock →

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.

Health Care · Misc Health and Biotechnology Services · 72 employees

AGL vs CCEL FAQ

Which is bigger, agilon health inc. or Cryo-Cell International?

agilon health inc. (AGL) is larger, with a market capitalization of $1.52B compared with $33.46M for Cryo-Cell International (CCEL).

Which stock has performed better over the past year, AGL or CCEL?

AGL returned +481.26% over the past 12 months, compared with +1.47% for CCEL (price return, excluding dividends). Past performance does not predict future results.

Are agilon health inc. and Cryo-Cell International in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons